Phase 4RecruitingHealthspan endpoint

Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance (PACE-UP)

Sponsor
Benedict Alter (Academic or other)
Enrollment
85 planned
Conditions
Knee Osteoarthritis (Knee OA); Chronic Pain; Chronic Knee Pain
Interventions
Duloxetine; Placebo
Ages
adults, older adults
Registry
NCT07759336

Full record on ClinicalTrials.gov

From the registry

The goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Researchers will compare duloxetine to a placebo (a look-alike substance that contains no drug) to see if duloxetine works to improve walking ability in patients with knee osteoarthritis. At study visits, participants will complete surveys, perform physical function tasks, undergo non-invasive brain imaging, and undergo sensory testing.

Primary outcomes

  • Distance walked in the 6-minute walking test

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Started

  5. Registered